Skip to menu Skip to content Skip to footer
Dr Yee Weng Wong
Dr

Yee Weng Wong

Email: 

Overview

Background

Dr. Yee Weng Wong is a clinical cardiologist with sub-specialty interests in cardiomyopathy, heart failure, cardiac transplantation and adult mechanical circulatory support.

In addition to his clinical interest, Dr Wong is an early career clinician researcher, with focus on translational research in reducing the morbidity and mortality associated with heart failure and development of novel therapeutic targets. Dr Wong is also committed in bringing his clinical and quantitative perspective to healthcare system improvement and implementation science initiatives.

Availability

Dr Yee Weng Wong is:
Available for supervision
Media expert

Research interests

  • Clinical Trials

  • Health Service Research

  • Artificial Intelligence in Medicine

  • Registry

  • Heart Failure

  • Cardiac Transplantation

  • Mechanical Circulatory Support

Works

Search Professor Yee Weng Wong’s works on UQ eSpace

70 works between 2006 and 2025

21 - 40 of 70 works

2021

Conference Publication

High Pre-Donation Vasoactive Inotropic Score (VIS) May Be Associated with Increased Risk of Primary Graft Dysfunction in Cardiac Transplantation

Challa, A., Maddicks-Law, J., Mulligan, A., Prabhu, A. and Wong, Y. (2021). High Pre-Donation Vasoactive Inotropic Score (VIS) May Be Associated with Increased Risk of Primary Graft Dysfunction in Cardiac Transplantation. ISHLT2021 41st Annual Meeting & Scientific Sessions, Online, 24-28 April 2021. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.healun.2021.01.653

High Pre-Donation Vasoactive Inotropic Score (VIS) May Be Associated with Increased Risk of Primary Graft Dysfunction in Cardiac Transplantation

2021

Journal Article

Hypophosphatemia is common after intravenous ferric carboxymaltose infusion among patients with symptomatic heart failure with reduced ejection fraction

Dashwood, Alexander, Vale, Cassandra, Laher, Shaaheen, Chui, Fiona, Hay, Karen and Wong, Yee Weng (2021). Hypophosphatemia is common after intravenous ferric carboxymaltose infusion among patients with symptomatic heart failure with reduced ejection fraction. Journal of Clinical Pharmacology, 61 (4), 515-521. doi: 10.1002/jcph.1754

Hypophosphatemia is common after intravenous ferric carboxymaltose infusion among patients with symptomatic heart failure with reduced ejection fraction

2021

Conference Publication

Real World Experience with Transmedics Organ Care System in Cardiac Transplantation with Donor Organs Associated with Marginal Risk Factors

Wong, Y., Maddicks-Law, J., Raymond, P., Davidson, M., Thomson, B., Sharma, V., Javorsky, G. and Prabhu, A. (2021). Real World Experience with Transmedics Organ Care System in Cardiac Transplantation with Donor Organs Associated with Marginal Risk Factors. ISHLT2021 41st Annual Meeting & Scientific Sessions, Online, 24-28 April 2021. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.healun.2021.01.569

Real World Experience with Transmedics Organ Care System in Cardiac Transplantation with Donor Organs Associated with Marginal Risk Factors

2020

Journal Article

A rare case of severe nontropical isolated right ventricular endomyocardial fibrosis

Laher, Shaaheen, Wong, Yee Weng, Platts, David, Prabhu, Anil, Thomson, Bruce, Hamilton-Craig, Christian, Godbolt, David, Cheesman, Elizabeth and Dashwood, Alexander (2020). A rare case of severe nontropical isolated right ventricular endomyocardial fibrosis. JACC: Case Reports, 2 (13), 2078-2084. doi: 10.1016/j.jaccas.2020.09.042

A rare case of severe nontropical isolated right ventricular endomyocardial fibrosis

2020

Journal Article

Correction to “Understanding How Phosphorylation and Redox Modifications Regulate Cardiac Ryanodine Receptor Type 2 Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure”

Dashwood, Alexander, Beard, Nicole, Wong, Yee Weng, Haqqani, Haris, Cheesman, Elizabeth and Molenaar, Peter (2020). Correction to “Understanding How Phosphorylation and Redox Modifications Regulate Cardiac Ryanodine Receptor Type 2 Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure”. ACS Pharmacology and Translational Science, 3 (6), 1422-1422. doi: 10.1021/acsptsci.0c00148

Correction to “Understanding How Phosphorylation and Redox Modifications Regulate Cardiac Ryanodine Receptor Type 2 Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure”

2020

Journal Article

Understanding how phosphorylation and redox modifications regulate cardiac ryanodine receptor type 2 activity to produce an arrhythmogenic phenotype in advanced heart failure

Dashwood, Alexander, Cheesman, Elizabeth, Beard, Nicole, Haqqani, Haris, Wong, Yee Weng and Molenaar, Peter (2020). Understanding how phosphorylation and redox modifications regulate cardiac ryanodine receptor type 2 activity to produce an arrhythmogenic phenotype in advanced heart failure. ACS Pharmacology and Translational Science, 3 (4) acsptsci.0c00003, 563-582. doi: 10.1021/acsptsci.0c00003

Understanding how phosphorylation and redox modifications regulate cardiac ryanodine receptor type 2 activity to produce an arrhythmogenic phenotype in advanced heart failure

2020

Journal Article

Impact of patient and model of care factors on titration and tolerability of sacubitril/valsartan: an early Australian real-world experience

Dashwood, Alexander, Vale, Cassandra, Laher, Shaaheen, Chui, Fiona, Rheault, Haunnah, Gan, Jaclyn and Wong, Yee Weng (2020). Impact of patient and model of care factors on titration and tolerability of sacubitril/valsartan: an early Australian real-world experience. Heart, Lung and Circulation, 29 (11), 1688-1695. doi: 10.1016/j.hlc.2020.03.008

Impact of patient and model of care factors on titration and tolerability of sacubitril/valsartan: an early Australian real-world experience

2020

Conference Publication

Determining the properties of omecamtiv mecarbil on human explanted cardiac trabeculae and its interaction with current inotropes via the beta 1-adrenoceptor

Dashwood, A., Cheesman, E., Wong, Y., Haqqani, H. and Molenaar, P. (2020). Determining the properties of omecamtiv mecarbil on human explanted cardiac trabeculae and its interaction with current inotropes via the beta 1-adrenoceptor. 40th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation (ISHLT), Montreal, QC, Canada, 22 - 25 April 2020. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.healun.2020.01.427

Determining the properties of omecamtiv mecarbil on human explanted cardiac trabeculae and its interaction with current inotropes via the beta 1-adrenoceptor

2020

Conference Publication

Return of the MRA: Comparative Tolerability and Safety of ARNI With MRA Co-Prescription in HFrEF

Vale, C., Dashwood, A., Hay, K., Laher, S., Chui, F. and Wong, Y. (2020). Return of the MRA: Comparative Tolerability and Safety of ARNI With MRA Co-Prescription in HFrEF. 68th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 14th Annual Australia and New Zealand Endovascular Therapies Meeting, Online, 11–13 December 2020. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2020.09.169

Return of the MRA: Comparative Tolerability and Safety of ARNI With MRA Co-Prescription in HFrEF

2019

Journal Article

Orthotopic cardiac transplantation for Chagas cardiomyopathy in Australia

Rausch, Karen, Lau, Katherine, Ulett, Kimberly, Chan, Wandy, Javorsky, George, Wong, Yee W., Thompson, Bruce, Pauli, John, McKenzie, Scott, Horvath, Robert and Platts, David (2019). Orthotopic cardiac transplantation for Chagas cardiomyopathy in Australia. Internal Medicine Journal, 49 (9), 1194-1195. doi: 10.1111/imj.14421

Orthotopic cardiac transplantation for Chagas cardiomyopathy in Australia

2019

Conference Publication

Hypophosphataemia is common after intravenous ferric carboxymaltose infusion among patients with symptomatic heart failure

Dashwood, A., Chui, F., Laher, S., Vale, C., Chan, W., McKenzie, S. and Wong, Y. (2019). Hypophosphataemia is common after intravenous ferric carboxymaltose infusion among patients with symptomatic heart failure. 67th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 13th Annual Australia and New Zealand Endovascular Therapies Meeting, Adelaide, SA Australia, 8-11 August 2019. Chatswood, NSW Australia: Elsevier Australia. doi: 10.1016/j.hlc.2019.06.094

Hypophosphataemia is common after intravenous ferric carboxymaltose infusion among patients with symptomatic heart failure

2019

Conference Publication

Translation of clinical trial to real world practice: can sacubitril-valsartan be safely titrated to target dose, 97/103mg bi-daily, in clinical practice and what baseline characteristics predict successful titration?

Dashwood, Alexander, Vale, Cassandra, Laher, Shaaheen, Rheault, Haunnah, Mckenzie, Scott and Wong, Yee Weng (2019). Translation of clinical trial to real world practice: can sacubitril-valsartan be safely titrated to target dose, 97/103mg bi-daily, in clinical practice and what baseline characteristics predict successful titration?. 68th Annual Scientific Session and Expo of the American-College-of-Cardiology (ACC), New Orleans, LA, United States, 16-18 March 2019. San Diego, CA, United States: Elsevier. doi: 10.1016/s0735-1097(19)31312-9

Translation of clinical trial to real world practice: can sacubitril-valsartan be safely titrated to target dose, 97/103mg bi-daily, in clinical practice and what baseline characteristics predict successful titration?

2018

Journal Article

Effects of once-weekly exenatide on clinical outcomes in patients with preexisting cardiovascular disease: prespecified analysis from EXSCEL

Mentz, Robert J., Thompson, Vivian P., Aguilar, David, Choi, Jasmine, Gustavson, Stephanie M., Iqbal, Nayyar, Kong, Alice P., Ohman, Peter, Sattar, Naveed, Scott, Russell S., Wong, Yee Weng, Holman, Rury R. and Hernandez, Adrian F. (2018). Effects of once-weekly exenatide on clinical outcomes in patients with preexisting cardiovascular disease: prespecified analysis from EXSCEL. Circulation, 138 (22), 2576-2578. doi: 10.1161/CIRCULATIONAHA.118.036811

Effects of once-weekly exenatide on clinical outcomes in patients with preexisting cardiovascular disease: prespecified analysis from EXSCEL

2018

Journal Article

Right heart catheterisation: how to do it

Krishnan, Anish, Markham, Ryan, Savage, Michael, Wong, Yee-Weng and Walters, Darren (2018). Right heart catheterisation: how to do it. Heart Lung and Circulation, 28 (4), 1-8. doi: 10.1016/j.hlc.2018.08.005

Right heart catheterisation: how to do it

2018

Conference Publication

Gender differences in patient characteristics and quality-of-care indicators among referrals to Queensland statewide heart failure support services

Wong, Y., Hickey, A., Nunan, T., Adsett, J., Denaro, C., Peters, R. and Atherton, J. (2018). Gender differences in patient characteristics and quality-of-care indicators among referrals to Queensland statewide heart failure support services. 66th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 12th Annual Australia and New Zealand Endovascular Therapies Meeting, Brisbane, Australia, 2-5 August 2018. Chatswood, NSW, Australia: Elsevier . doi: 10.1016/j.hlc.2018.06.137

Gender differences in patient characteristics and quality-of-care indicators among referrals to Queensland statewide heart failure support services

2018

Conference Publication

Explant of heartware biventricular assist devices following myocardial recovery after peripartum cardiomyopathy

Lau, K., Bancroft, J., McKenzie, S., Javorsky, G., Chan, W., Wong, Y., Thomson, B., Prabhu, A., Fraser, J. and Platts, D. (2018). Explant of heartware biventricular assist devices following myocardial recovery after peripartum cardiomyopathy. 66th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 12th Annual Australia and New Zealand Endovascular Therapies Meeting, Brisbane, QLD Australia, 2-5 August 2018. Chatswood, NSW Australia: Elsevier Australia. doi: 10.1016/j.hlc.2018.06.126

Explant of heartware biventricular assist devices following myocardial recovery after peripartum cardiomyopathy

2018

Conference Publication

Early real-world experience of tolerability and titration rates of angiotensin-receptor-neprilysin inhibitor

Vale, C., Gan, J., McKenzie, S., Wong, Y., Rheault, H., Laher, S. and Dashwood, A. (2018). Early real-world experience of tolerability and titration rates of angiotensin-receptor-neprilysin inhibitor. Abstracts for the 66th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 12th Annual Australia and New Zealand Endovascular Therapies Meeting, Brisbane, QLD Australia, 2-5 August 2018. Chatswood, NSW Australia: Elsevier Australia. doi: 10.1016/j.hlc.2018.06.117

Early real-world experience of tolerability and titration rates of angiotensin-receptor-neprilysin inhibitor

2018

Conference Publication

From hospital to home: insights from the Queensland Statewide Heart Failure Support Services registry on heart failure transitional care

Wong, Y., Nunan, T., Hickey, A., Denaro, C., Adsett, J., Peters, R. and Atherton, J. (2018). From hospital to home: insights from the Queensland Statewide Heart Failure Support Services registry on heart failure transitional care. 66th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 12th Annual Australia and New Zealand Endovascular Therapies Meeting, Brisbane, QLD Australia, 2-5 August 2018. Chatswood, NSW Australia: Elsevier Australia. doi: 10.1016/j.hlc.2018.06.135

From hospital to home: insights from the Queensland Statewide Heart Failure Support Services registry on heart failure transitional care

2018

Conference Publication

Chest pain: a rare case of pulmonary arteriovenous malformation

Lee, T. and Wong, Y. (2018). Chest pain: a rare case of pulmonary arteriovenous malformation. 66th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 12th Annual Australia and New Zealand Endovascular Therapies Meeting, Brisbane, Australia, 2-5 August 2018. Chatswood, NSW, Australia: Elsevier . doi: 10.1016/j.hlc.2018.06.412

Chest pain: a rare case of pulmonary arteriovenous malformation

2018

Conference Publication

Rare case of advanced non-tropical, isolated right ventricular endomyocardial fibrosis

Dashwood, A., Rusli, S., Thomson, B., Prabhu, A., Platts, D., Korczyk, D., Hill, J., Godbolt, D., Small, A. and Wong, Y. (2018). Rare case of advanced non-tropical, isolated right ventricular endomyocardial fibrosis. 66th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 12th Annual Australia and New Zealand Endovascular Therapies Meeting, Brisbane, QLD Australia, 2-5 August 2018. Chatswood, NSW Australia: Elsevier Australia. doi: 10.1016/j.hlc.2018.06.181

Rare case of advanced non-tropical, isolated right ventricular endomyocardial fibrosis

Funding

Past funding

  • 2021 - 2023
    Anti-arrhythmic medicines: a new prototype targeting the ryanodine channel (RyR2) to reduce sudden death in heart failure patients
    Prince Charles Hospital Foundation
    Open grant
  • 2019 - 2024
    New Medicines to Keep Heart Failure Patients Alive
    Prince Charles Hospital Foundation
    Open grant

Supervision

Availability

Dr Yee Weng Wong is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Understanding How Phosphorylative and Oxidative Stress Regulate Cardiac Ryanodine Receptor-Type 2 Gating Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure

    Associate Advisor

    Other advisors: Honorary Professor Peter Molenaar

  • Doctor Philosophy

    Cause and prevention of stress induced arrhythmias in human heart

    Associate Advisor

    Other advisors: Honorary Professor Peter Molenaar

Media

Enquiries

Contact Dr Yee Weng Wong directly for media enquiries about:

  • AI in healthcare
  • clinical trials
  • Healthcare system improvement
  • heart failure

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au